TotalMarketCap

Purple Biotech

PPBTNasdaq IsraelHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$2.017 M

$1.24 +2.06%

Close of 6 Nov 2026

As of 6 Nov 2026, Purple Biotech (PPBT) has a market capitalization of $2.02M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

1,858,911,801

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #481Sunshine BiopharmaSBFM$2.16M
  2. #482Revelation BiosciencesREVB$2.03M
  3. #483Purple BiotechPPBT$2.02M
  4. #484GeoVax LabsGOVX$1.95M
  5. #485EnlivexENLV$1.95M

What if Purple Biotech were worth as much as…

Open the what-if tool →

Gold $28.2T

$17,356,597

Per share 13,997,256× higher

Bitcoin $1.53T

$939,135.24

Per share 757,367× higher

Apple $5.02T

$3,083,093

Per share 2,486,366× higher

Or at a round number

$5.00M$10.0M$20.0M$50.0M

Where these numbers come from

Share counts and financials for Purple Biotech are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.